Discovering Factors in the Clinical Study Journey of Patients With OCD
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT05881356
- Status
- Recruiting
Conditions
- OCD
- Obsessive-Compulsive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future OCD patients.
Key Dates
- Start date
- Jun 30, 2024
- Status verified
- May 2023
- Primary completion
- Jun 30, 2025
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Rate of participants who decide to enroll in a OCD clinical study. [ Time Frame: 3 months ]
Central Contacts
- Michael B Gill415-900-4227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 |
Find similar trials in San Francisco, CA
By research site
Related Studies
- Efficacy of Nitrous Oxide in OCD: Pilot StudyPHASE2 · Recruiting · Stanford University · Stanford, California
- Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum DisordersRecruiting · Stanford University · Stanford, California
- Study of Dextromethorphan in OCD and Related DisordersPHASE2 · Recruiting · Stanford University · Stanford, California
- Cortical Stimulation to Treat Obsessive Compulsive DisorderRecruiting · Andrew Moses Lee, MD, PhD · San Francisco, California